Glucose uptake after resistance training of different intensities but of equal work volume.
High-intensity (HI) resistance exercise augments postexercise glucose uptake to a greater degree than low-intensity (LO) resistance exercise; however, few studies have equated the work volumes between intensity levels. The purpose of this study was to compare the effect of acute HI and LO resistance exercise of equal work volume on glucose uptake in resistant-trained men. Fifteen healthy male (22.9 +/- 3.8 years old), resistance-trained (6.7 +/- 3.9 years) subjects completed three treatment sessions: CON (no-exercise control), HI (3 x 8, 85% 10-RM), and LO (3 x 15, 45% 10-RM). HI and LO sessions consisted of eight exercises. Glucose uptake was measured the following morning by using the hyperinsulinemic euglycemic clamp technique. Glucose disposal was measured by analyzing the glucose infusion rate during the final 30 minutes of steady-state blood glucose concentrations. Insulin sensitivity was calculated by dividing the glucose infusion rate by the average insulin infusion. Results indicate that fasting blood glucose levels were not significantly different among treatment sessions (CON = 80.5 +/- 5.3 versus HI = 77.0 +/- 4.9 versus LO = 77.1 +/- 6.0 mg.dL). Glucose uptake was not significantly different among treatment sessions (CON = 11.3 +/- 3.0 versus HI = 11.7 +/- 2.7 versus LO = 11.4 +/- 2.8 mg.kg FFM.min). Insulin sensitivity did not change among treatment sessions (CON = 0.26 +/- 0.09 versus HI = 0.28 +/- 0.07 versus LO = 0.27 +/- 0.06 (mg.kg FFM.min)/(uU.mL)). The data indicate that the resistance training sessions did not modify acute insulin sensitivity. This may have been because of the high levels of fitness of the subjects, which allowed for the cellular adaptations for enhanced insulin sensitivity and glucose uptake that are unaffected by this volume of acute exercise.
Department of Health, Physical Education, and Recreation, Emporia State University, Emporia, Kansas, USA. pluebber@emporia.edu
Paul E
PE
Luebbers
Jeffrey A
JA
Potteiger
Beverly J
BJ
Warren
John N
JN
Clore
Chris
C
Jennings
Dale S
DS
Bond
D000328:Adult; D001786:Blood Glucose / Q000032:analysis; D002021:Buffers; D005215:Fasting; D005947:Glucose / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007328:Insulin / Q000008:administration & dosage / Q000097:blood; D008297:Male; D010710:Phosphates; D010806:Physical Education and Training / Q000379:methods*; D017680:Potassium Compounds; D013549:Sweetening Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*
D001786:Blood Glucose; D002021:Buffers; D007004:Hypoglycemic Agents; D007328:Insulin; D010710:Phosphates; D017680:Potassium Compounds; D013549:Sweetening Agents; C013216:potassium phosphate; D005947:Glucose